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Polyamine analogues: potent inducers of nucleosomal array
oligomerization and inhibitors of yeast cell growth
Lenny M. CARRUTHERS*, Laurence J. MARTON† and Craig L. PETERSON*1
*Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Drive, Biotech 2, Suite 210, Worcester, MA 01605, U.S.A., and †Cellgate,
3 Twin Dolphin Dr., Suite 100, Redwood City, CA 94065-1517, U.S.A.
Polyamines are naturally occurring intracellular polycations that
are essential for viability and growth of eukaryotes. Dysregul-
ation of polyamine metabolism is a hallmark of cancer and the
carcinogenic process, and consequently development of poly-
amine analogues has emerged as a viable strategy for therapeutic
intervention. Previously, we showed that the naturally occurring
polyamines spermidine and spermine were quite effective at
inducing the oligomerization of nucleosomal arrays in vitro,
suggesting that polyamines may play a key role in regulating
higher order chromatin structures in vivo. Here, we analyse the
ability of a number of synthetic polyamine analogues to potentiate
formation of higher order chromatin structures in vitro. We find
that a class of long-chain polyamines called oligoamines are
potent inducers of nucleosomal array oligomerization in vitro
and that these same polyamine analogues rapidly block yeast cell
growth.
Key words: chromatin, nucleosomal array, oligoamine, polyamine
analogue, spermine, yeast.
INTRODUCTION
The polyamines, putrescine, spermidine and spermine, are natur-
ally occurring intracellular polycations that are essential for
viability and growth of eukaryotes [1–3]. Polyamines are synthe-
sized by an exquisitely regulated biosynthetic pathway, and
regulation of their catabolism and transport is likewise finely
tuned [1,4,5]. Dysregulation of these pathways is the hallmark
of cancer and the carcinogenic process. Elevations of polyamine
levels and of the polyamine biosynthetic enzyme ODC (ornithine
decarboxylase) are observed in neoplastic tissues and are induced
by the application of tumour promoters [4]. ODC transcription is
a target for the proto-oncogene c-myc [6,7], and activation of c-
jun and c-fos pathways involves polyamines [8]. Overexpression
of ODC has been shown to transform cells in culture, and high
levels of ODC production in transgenic mice cause increased
susceptibility to tumour formation [4]. Thus the polyamine
pathway has been identified as a target for therapeutic intervention
for cancer, as well as for other hyperproliferative diseases.
While pharmacological inhibition of polyamine biosynthetic
enzymes has found some clinical utility, inherent problems related
to the availability of polyamines in food and from normal
bacterial flora in the gastrointestinal tract have necessitated the
evolution of new approaches to the creation of potentially useful
compounds. The development of a variety of polyamine analogues
that gain entry into cells through active polyamine transport, that
may modulate normal polyamine biosynthesis through natural
feedback mechanisms, that may up-regulate catabolism and, im-
portantly, that may compete with natural polyamines for intra-
cellular binding sites, but with altered function, is an emerging
approach that is now being tested clinically [9–14].
While the biochemistry and molecular biology of the poly-
amines are being elucidated rapidly, knowledge of their specific
molecular functions is more embryonic. Emerging functions
include association with nucleic acids [15], maintenance and
modulation of structure and function of chromatin [16,17],
regulation of specific gene expression, ion channel regulation [18],
maintenance of membrane stability [19], essential incorporation
into active eIF5A (eukaryotic translation initiation factor 5A)
[20] and free radical scavenging. Of particular interest are the
effects of polyamines on chromatin structure. Previously we found
that depletion of cellular polyamines bypassed the transcriptional
requirements for the yeast histone acetyltransferase Gcn5p [17].
Furthermore, we found that polyamines facilitated nucleosomal
array condensation in vitro and that this activity was antagonized
by histone hyperacetylation [17]. These genetic and biochemical
data indicated that cellular polyamines function in opposition to
chromatin-modifying enzymes to facilitate formation of chro-
matin higher order structures, leading to transcriptional re-
pression. Likewise, Gilmour and co-workers [21–23] have found
that increased levels of polyamines in mammalian cells also lead
to changes in chromatin structure and alterations in the activities of
histone-modifying activities. Thus it seems likely that chromatin
is a key cellular target for polyamines and that dysregulation of
this chromatin function may play a key role in development or
progression of cancers.
Given the therapeutic promise of several polyamine analogues,
we have investigated the potency of a variety of polyamine
analogues in facilitating condensation of chromatin in vitro.
All polyamine analogues tested retained the ability to induce
oligomerization of nucleosomal arrays in vitro, and our results
lead to a classification of polyamine analogues into the following
two groups: (i) group I analogues are similar in potency to the
natural polyamine, spermine, in chromatin condensation assays,
and (ii) group II analogues are 3–4-fold more potent than sper-
mine, and thus induce chromatin condensation at low micromolar
concentrations. These novel group II polyamine analogues are
composed mostly of oligoamines [24], and each member of this
class is a potent inhibitor of yeast cell growth. Previous studies
have indicated that members of the group II class of polyamine
analogues show promise as therapeutics for treatment of breast
cancer and other cancers [25], and our results suggest that
chromatin structure may play a role as a key molecular
target.
Abbreviation used: ODC, ornithine decarboxylase.
1 To whom correspondence should be addressed (email craig.peterson@umassmed.edu).
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Figure 1 Schematic representation of polyamine analogues
EXPERIMENTAL
Polyamine analogues
The polyamine analogues were obtained from Cellgate and each
was resuspended in sterile water and stored at −20 ◦C. These
compounds are highly stable in aqueous solutions even at elevated
temperature.
Nucleosomal array reconstitution
Array DNA template was isolated by digestion of plasmid pCL7c
with NotI, HindIII and HhaI (New England Biolabs) followed
by FPLC purification on Sephacryl-500 (Amersham Biosciences)
essentially as described in [26,27]. Chicken erythrocyte histone
octamers were purified from chicken whole blood (Pel-Freez
Biologicals) as described previously [28]. Arrays were recon-
stituted on to the 208-11S DNA template in a Slide-a-Lyzer dia-
lysis cassette (Pierce) by using the salt dialysis protocol of Hansen
et al. [29]. Octamer concentrations were determined by measuring
A230 (absorbance) [30].
Array oligomerization assay
Arrays (50 nM) were incubated with polyamines or polyamine
analogues in TE buffer (10 mM Tris, pH 7.4, and 0.1 mM EDTA).
Samples were incubated for 15 min at room temperature (24 ◦C),
and then samples were centrifuged for 10 min in a microfuge. A260
of the resulting supernatant was then determined and compared
with the initial reading prior to polyamine addition to yield the
percentage array remaining in supernatant.
Analysis of polyamine levels within yeast cells
Yeast cultures (50 ml) were grown at 30 ◦C in rich YPD medium
[1% (w/v) yeast extract, 2% (w/v) bactopeptone and 2% (w/v)
glucose] to an A600 of 1.0. Polyamine analogues were added
to 100 µM final concentration and cultures were grown for an
additional 2 h at 30 ◦C. An identical cell culture was grown in the
absence of polyamine analogue. Cells were harvested by centri-
fugation (4000 g for 5 min at 4 ◦C) and washed three times with
distilled water. Cell pellets (0.25 g) were resuspended in ice-cold
5% HClO4 and a cell pellet volume equivalent of zirconium
beads (Biospec Products) was added. Cells were broken by
vigorous vortex-mixing. Extracts were clarified by centrifugation
(14000 g for 10 min at 4 ◦C), and extracts were stored at −20 ◦C.
Polyamine extracts were subjected to dansylation reactions and
analysed by HPLC. Since different preparations vary due to
different efficiencies of cell breakage, polyamine analogue levels
were normalized to spermine, since spermine levels are relatively
constant within cells.
RESULTS AND DISCUSSION
In order to investigate the potential for various polyamine ana-
logues to induce chromatin condensation, model nucleosomal
arrays were reconstituted with purified histones. Nucleo-
somal arrays were assembled by salt dialysis using purified
chicken erythrocyte histone octamers and a DNA template com-
posed of 11 head to tail repeats of a 208 bp 5S rRNA gene from
Lytechinus variegatus (208-12S template). Each 5S repeat can
rotationally and translationally position a nucleosome after in vitro
salt dialysis reconstitution, yielding a positioned array of nucleo-
somes. These model nucleosomal arrays undergo complex hier-
archical structural changes in vitro in the presence of bivalent
cations [31]. Low concentrations of Mg2+ ions (<2 mM) induce
intramolecular compaction of individual nucleosomal arrays
through association of neighbouring nucleosomes (‘folding’),
while progressively higher concentrations of Mg2+ (>2 mM
Mg2+) or low concentrations of polyamines (∼200 µM) can
induce nucleosomal arrays to reversibly oligomerize. The intra-
molecular folding of model arrays at low Mg2+ concentrations
is believed to mimic the formation of 30 nm-like chromatin fibres,
while intermolecular oligomerization generates relatively defined,
soluble structures that sediment in the thousands of S, and are
believed to mimic the fibre–fibre interactions that stabilize higher
order chromosomal domains such as chromonema fibres [16].
Figure 1 illustrates the polyamine analogues used in the
present study. Several of the analogues are conformationally re-
stricted spermine-like compounds (CGC-11047, CGC-11093,
c© 2007 Biochemical Society
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Figure 2 Representative nucleosomal array oligomerization profiles for
four different polyamine analogues
Nucleosomal arrays (50 nM) were incubated with increasing concentrations of spermine,
spermidine or the polyamine analogues CGC-11047 or CGC-11217 for 15 min at room
temperature. Samples were centrifuged for 10 min and the concentration of nucleosomal array
remaining in the supernatant was determined by measuring A 260.
Table 1 Summary of chromatin condensation by polyamine analogues
Values are means of at least three independent experiments. All analogues were assayed in
parallel.
Compound Concentration inducing 50 % chromatin condensation
Controls
Spermidine 140 µM
Spermine 18 µM
Group I analogues
CGC-11047 36 µM
CGC-11102 20 µM
CGC-11093 16 µM
CGC-11098 18 µM
CGC-11237 60 µM
Group II analgoues
CGC-11157 5 µM
CGC-11158 5 µM
CGC-11150 5 µM
CGC-11144 4 µM
CGC-11217 7 µM
CGC-11098 and CGC-11102) [32], several analogues are longer
chain oligoamines (CGC-11157, CGC-11158, CGC-11144 and
CGC-11150), while CGC-11217 is mesoporphyrin IX covalently
bound to two molecules of CGC-11093, and CGC-11237 is
mesoporphyrin IX covalently bound to two molecules of a cyclic
polyamine. All of these compounds are active against a variety
of human tumour cells both in vitro and in vivo [9,12,24,25,32].
CGC-11047 and CGC-11093 are in human clinical trials.
Polyamine analogues induce chromatin condensation
To investigate the ability of polyamine analogues to induce oligo-
merization of nucleosomal arrays, increasing concentrations of
each polyamine analogue were incubated with nucleosomal arrays
(50 nM) for 10 min at room temperature, and oligomerized
arrays were pelleted by centrifugation. The amount of array re-
maining in the supernatant was then quantified and plotted as a
function of analogue concentration. Similar to our previous study
[17], spermidine was quite effective at oligomerizing nucleosomal
arrays, as a concentration of 140 µM was sufficient to oligomerize
50% of the arrays (Figure 2 and Table 1). Spermine was approx.
10-fold more potent than spermidine, as 50% oligomerization
occurred at 18 µM. When each of the analogues was analysed
in parallel, two groups emerged from the data (Figure 2 and
Figure 3 Polyamine analogues synergize with spermidine for chromatin
condensation
Nucleosomal arrays (50 nM) were incubated with 80 µM spermidine for 5 min at room
temperature. Group I (A) or group II (B) polyamine analogues were then added at varying
concentrations and the incubation was continued for 15 min. Nucleosomal array oligomerization
was then assayed as in the legend of Figure 2.
Table 1). Group I analogues were similar in effectiveness to
spermine, with 50% oligomerization occurring between 16 and
60 µM concentrations (CGC-11047, CGC-11093, CGC-11098,
CGC-11102 and CGC-11237). On the other hand, group II
analogues were clearly more effective than spermine, with oligo-
merization requiring only 4–7 µM of each compound (CGC-
11157, CGC-11158, CGC-11144, CGC-11150 and CGC-11217).
Interestingly, with only one exception, CGC-11217, all of the
group II polyamine analogues are oligoamines, indicating that
potent nucleosomal array oligomerization is a common feature of
this class of compounds.
In a therapeutic setting, polyamine analogues must compete
with cellular polyamine pools for interactions with cellular targets
such as chromatin. One possibility is that chromatin, which is
already bound by cellular polyamines, will be insensitive to the ef-
fects of polyamine analogues added subsequently. To test this idea,
nucleosomal arrays were pre-incubated with 80 µM spermid-
ine, a concentration in which ∼95% of the arrays are soluble, and
then increasing concentrations of the polyamine analogues were
added and array oligomerization was assayed by centrifugation.
As shown in Figure 3, prebinding spermidine to nucleosomal
arrays did not inhibit the ability of the polyamine analogues
to mediate array oligomerization. For instance, analogue CGC-
11102 which induces 50% oligomerization at ∼20 µM by
itself, only requires ∼10 µM when the arrays were prebound
by low concentrations of spermidine. Likewise, each of the group
II polyamine analogues (e.g. CGC-11144) were potent in the
presence of spermidine, with greater than 50% oligomerization
occurring at 2.5 µM. Thus the results suggest that endogenous
polyamines do not grossly antagonize polyamine analogue-
mediated nucleosomal array oligomerization.
c© 2007 Biochemical Society
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Figure 4 Group II polyamine analogues inhibit yeast cell growth
Yeast cells (CY1019) were grown at 30◦C in rich YPD medium until mid-exponential phase and then diluted to an A 600 of 0.1 prior to addition of spermine (A), spermidine (A), CGC-11047 (B),
CGC-11144 (C), CGC-11150 (D), CGC-11157 (E) or CGC-11158 (F) at the indicated concentrations. Cultures were grown at 30◦C with shaking and A 600 was monitored at the indicated times.
Results shown are representative of at least two independent experiments. spm, spermine; spd, spermidine.
Group II polyamine analogues inhibit yeast cell growth
The potent chromatin condensation activity of the group II poly-
amine analogues may have a detrimental effect on cell growth
and/or nuclear function. As an initial investigation, increasing
concentrations of each polyamine analogue were added to cultures
of yeast cells and growth rates were monitored over time. A repre-
sentative set of results for a subset of the polyamine analogues is
shown in Figure 4. As was the case for the chromatin condensation
assays, these yeast cell studies were consistent with the classi-
fication of the polyamine analogues into the same two groups.
The group I polyamine analogues were identical with spermine
and spermidine, as no effects were observed on yeast cell growth
at the concentrations used (10–100 µM). In contrast, the group II
polyamine analogues, which were more potent in chromatin
condensation, dramatically inhibited yeast cell growth within the
first cell cycle following addition of the polyamine analogue. For
instance, the group II analogue, CGC-11144, blocked yeast cell
growth at a concentration of 40 µM, while addition of 100 µM of
any of the group I analogues had no detrimental effect. Previous
studies have shown that polyamine synthesis is required for yeast
cell growth and that depletion of cellular polyamines leads to cell
cycle arrest in the G1-phase of the cell cycle [33,34]. Likewise,
FACS analysis indicates that yeast cells treated with the group II
analogue, CGC-11144, rapidly accumulate in G1 (results not
shown). Thus the ability of polyamine analogues to inhibit yeast
cell growth correlates quite well with their ability to induce
chromatin condensation.
One possibility is that the toxicity of group II polyamines may
be due to enhanced uptake or stability within yeast cells compared
with group I polyamines. To test this idea, yeast cultures were
treated for 2 h with 100 µM CGC-11144 or CGC-11093, cells
were harvested, and 5% HClO4 extracts were analysed for poly-
amine content by HPLC analysis. Results from two independent
extracts indicate that both of the polyamine analogues accumulate
to similar levels within yeast cells. The class I analogue CGC-
11093 was found at 183 +− 9 nmol/g of yeast cells (normalized
to endogenous spermine levels), while the potent class II ana-
logue CGC-11144 was found at 150 +− 22 nmol/g of yeast cells(normalized to endogenous spermine). In both cases polyamine
analogues were ∼10% the level of cellular spermidine. Thus
these results indicate that the increased toxicity of the class II poly-
amine analogues is not due to greatly enhanced uptake, but that
this phenotype may be due to their effects on chromatin structure.
As select polyamine analogues are being advanced in pre-
clinical and clinical studies for cancer and other hyperprolifer-
ative diseases, such as macular degeneration, further understand-
ing of the mechanisms of action of these compounds is essential.
c© 2007 Biochemical Society
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Recent results showing that intracellular polyamine levels can
modulate the activity of HDAC (histone deacetylase) inhibitors
[21] and that the histone lysine-specific demethylase LSD1
(lysine-specific demethylase 1) shares significant characteristics
with spermine oxidase [35] further tie the polyamines to the regul-
ation of chromatin structure and function. Of particular interest is
the fact that the presence of the natural polyamine spermidine
does not interfere with the oligomerization activity of the
polyamine analogues studied. The unexpected outcome of these
experiments lends further credence to the potential intracellular
utility of these compounds. Finally, just as the oligoamines’ parti-
cular abilities to oligomerize arrays in the present study correlate
with their cell-killing ability against yeast, a similar correlation
between oligoamines and their ability to aggregate DNA has been
shown for human prostate cells in culture [24]. The critical roles
that polyamines play in all cells suggest the potential therapeutic
utility of their analogues in a wide spectrum of diseases.
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